Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.44 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.42 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.42 |
| ▸ | RAMP3 | O60896 | 8/20 | 0.41 |
| ▸ | CALCR | P30988 | 8/20 | 0.41 |
| ▸ | APLNR | P35414 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29904041 | 0.94 | APLNR (0.41) | OPRM1OPRD1NMUR2NMUR1APLNR | |
| SCHEMBL30493464 | 0.93 | APLNR (0.42) | OPRM1OPRD1NMUR2NMUR1RAMP3 | |
| SCHEMBL29800885 | 0.91 | NAA50 (0.47) | OPRM1OPRD1NMUR2NMUR1APLNR | |
| SCHEMBL29801129 | 0.90 | PTPN1 (0.45) | OPRD1NMUR2NMUR1RAMP3CALCR | |
| SCHEMBL29904042 | 0.89 | APLNR (0.42) | OPRM1OPRD1NMUR2NMUR1APLNR | |
| SCHEMBL29569246 | 0.89 | NTSR1 (0.44) | OPRD1APLNR | |
| SCHEMBL29800900 | 0.88 | NTSR1 (0.48) | OPRD1 | |
| SCHEMBL30933089 | 0.88 | NAA50 (0.48) | NMUR2NMUR1RAMP3CALCRAPLNR | |
| SCHEMBL5495351 | 0.87 | NAA50 (0.54) | NMUR2NMUR1RAMP3CALCRAPLNR | |
| SCHEMBL29801041 | 0.87 | OPRM1 (0.55) | OPRM1OPRD1NMUR2NMUR1RAMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109422799-B | Docetaxel liver cancer-resisting targeted prodrug and medicinal application thereof | 复旦大学 | 2022-07-29 | — | — | CN | claimed |
| CN-109422799-B | Docetaxel liver cancer-resisting targeted prodrug and medicinal application thereof | 复旦大学 | 2022-07-29 | — | — | CN | disclosed |